Penny stocks can look risky at first glance, but in a world where central banks are constantly reassessing interest rates, inflation is pulled around by energy prices, and growth signals differ from one region to the next, a Financially Fit Penny Stocks screener offers a way to focus on smaller companies that put financial health first. This article highlights how that focus can help you narrow a crowded field, then walks through 3 stocks from our screener, chosen for their balance of early stage potential and stronger balance sheet quality compared with many other low priced stocks.

Grab Holdings (GRAB)

Overview: Grab Holdings runs a superapp across eight Southeast Asian countries that brings together ride-hailing, food and grocery delivery, digital payments, banking, lending, insurance, advertising and travel services into a single everyday platform for consumers and merchants.

Operations: Grab generates most of its revenue from Deliveries at US$1.9b and Mobility at US$1.3b, with Financial Services contributing US$379m and Other activities US$4m.

Market Cap: US$14.3b

Grab Holdings catches the eye in a penny stock screener because it combines a broad superapp footprint with improving fundamentals, including a net profit margin of 10.7% and record adjusted EBITDA of US$154m in Q1 2026 alongside reaffirmed full year guidance. At the same time, the stock trades well below some fair value estimates, even as analysts expect earnings growth that outpaces the wider US market, which is an unusual mix of quality and pricing for this part of the market. Investors do need to weigh high non cash earnings, funding fully reliant on external borrowing and a relatively new board, but for those who want exposure to Southeast Asia’s digital economy, the full risk reward picture for Grab is worth a closer look.

Grab Holdings is already posting a 10.7% net profit margin and record adjusted EBITDA of US$154m, yet still screens as undervalued. The real tension is whether the price fully reflects its risks, which is exactly what the 4 key rewards and 1 important major warning sign

Marqeta (MQ)

Overview: Marqeta runs a cloud based platform that helps businesses issue debit, credit, prepaid and virtual cards, and process those transactions in real time, using open APIs so customers like fintechs, lenders and e commerce companies can build tailored payment experiences on top of its infrastructure.

Operations: Marqeta generates about US$651.6m in revenue from data processing services, with roughly US$551.2m coming from the United States and US$100.4m from markets outside the US.

Market Cap: US$1.6b

Marqeta stock sits in the Financially Fit Penny Stocks screener because it combines a payment infrastructure role in fast growing areas like BNPL, neobanking and expense management with early profitability signals, including recent GAAP profits and an improving, though still fragile, 0.3% net margin. Investors get exposure to themes such as AI powered fraud controls, European expansion and potential stablecoin card programs, but must weigh meaningful risks such as heavy customer concentration, regulatory pressure and a funding base made up entirely of higher risk external borrowing rather than deposits. For investors monitoring whether earnings growth forecasts above 40% can translate into durable, cash backed returns, the balance of potential and execution risk at Marqeta may warrant closer attention.

Marqeta’s early profitability and 0.3% net margin hint at a business that could be turning a corner, but the real story sits inside the analyst forecasts for Marqeta and what it suggests about how long that margin holds.

Clover Health Investments (CLOV)

Overview: Clover Health Investments provides Medicare Advantage plans in the United States and offers preferred provider organization and health maintenance organization options to Medicare eligible individuals, supported by its Clover Assistant software platform that helps physicians detect, identify and manage chronic diseases.

Operations: Clover Health Investments generates about US$2.2b in revenue from its Insurance segment, all from customers in the United States.

Market Cap: US$2.6b

Clover Health Investments stands out in a penny stock screener because it sits at the intersection of Medicare Advantage growth, healthcare technology and a business that has recently reported a swing to net income of US$27.33m on quarterly revenue of US$749.19m. The upgrade to a 4.5 star rating for its PPO plans and the broader rollout of Clover Assistant give the company more levers to improve margins. However, investors still face real questions around medical cost trends, reliance on higher risk external funding and the fact that consensus price targets sit below the current share price. Understanding how those moving parts fit together, and what the latest analyst earnings and revenue assumptions really imply, is where the more interesting story begins.

Clover Health’s swing to US$27.33m in net income and a 4.5 star PPO rating hints at a story that many investors might be underestimating, but the real twist sits inside the analyst forecasts for Clover Health Investments

The three penny stocks in this article are only a small sample, with the full screener surfacing 333 more companies that pair low share prices with financial stories that could be just as compelling as Grab, Marqeta and Clover Health. Use Simply Wall St to identify and analyze the specific catalysts and narratives that matter to you, from balance sheet strength to earnings momentum, with the Financially Fit Penny Stocks screener.

Take Control of Your Investment Journey

If Marqeta or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Stock Ideas Today?

Fresh opportunities do not stay under the radar for long, and the best breakout setups can get caught once momentum starts flying. Scan these curated ideas now and consider them while they are still early.

• Track cash rich businesses built to absorb shocks and still pursue growth with a curated set of resilient companies in the list of solid balance sheet and fundamentals (48 results).
• Spot strong cash generators offering higher income potential by focusing on companies inside the 8 dividend fortresses before yields change and attention increases.
• Follow long term demand for critical resources by reviewing producers highlighted in the 8 top copper producer stocks while they remain less widely followed for now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.